![Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2021204112/asset/images/medium/radiol.2021204112.fig2a.gif)
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
![Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? | SpringerLink Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-019-02899-0/MediaObjects/345_2019_2899_Fig4_HTML.png)
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated? | SpringerLink
![Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | SpringerLink Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00261-021-03249-8/MediaObjects/261_2021_3249_Fig4_HTML.png)
Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | SpringerLink
![Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-10859-9/MediaObjects/41598_2022_10859_Fig1_HTML.png)
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
![In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43055-021-00543-9/MediaObjects/43055_2021_543_Fig2_HTML.png)
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text
![Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology](https://www.auajournals.org/cms/asset/177aac62-73ea-47d4-8c95-3be025375697/ju.0000000000001424f1.gif)
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
![Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80749-5/MediaObjects/41598_2020_80749_Fig1_HTML.png)
Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports
![Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system | Scientific Reports Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64693-y/MediaObjects/41598_2020_64693_Fig1_HTML.png)
Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system | Scientific Reports
![Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology](https://www.auajournals.org/cms/asset/472738d8-800f-4e0f-beec-1b864edf6d9e/abs-fig.jpg)
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
![An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The](https://www.thelancet.com/cms/attachment/0475a67e-32bd-4177-854e-bdca979e3ce1/gr1_lrg.jpg)
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The
![Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions | SpringerLink Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00261-022-03444-1/MediaObjects/261_2022_3444_Figa_HTML.png)
Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions | SpringerLink
![Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org](https://prod-images-static.radiopaedia.org/images/51527275/cd025d73e1febff0b375f93210e8ca_gallery.jpeg)
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
![Frontiers | New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting Frontiers | New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting](https://www.frontiersin.org/files/Articles/608409/fonc-11-608409-HTML-r1/image_m/fonc-11-608409-g001.jpg)
Frontiers | New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting
![PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143920305792-fx1.jpg)
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
![Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients - ScienceDirect Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0720048X19300373-gr1.jpg)